Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.

Weng HH, Ranganath VK, Khanna D, Oh M, Furst DE, Park GS, Elashoff DA, Sharp JT, Gold RH, Peter JB, Paulus HE; Western Consortium of Practicing Rheumatologists.

J Rheumatol. 2010 Mar;37(3):550-7. doi: 10.3899/jrheum.090818. Epub 2010 Jan 28.

2.

Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.

Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE; Western consortium of practicing rhuemotologists.

J Rheumatol. 2005 Jun;32(6):1040-2.

PMID:
15940764
3.
4.

Molecular-based methods for quantifying HIV viral load.

Peter JB, Sevall JS.

AIDS Patient Care STDS. 2004 Feb;18(2):75-9. Review.

PMID:
15006182
5.

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.

Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik M, Zampieri S, Peter JB, Favaretto E, Iaccarino L, Sherer Y, Todesco S, Pauletto P.

Ann Rheum Dis. 2003 Nov;62(11):1071-7.

6.

Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations--possible immunomodulation of atherosclerosis.

Wu R, Shoenfeld Y, Sherer Y, Patnaik M, Matsuura E, Gilburd B, Koike T, Peter JB.

Autoimmunity. 2003 Mar;36(2):91-7.

PMID:
12820691
7.

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW.

J Immunol Methods. 2003 Mar 1;274(1-2):27-35.

PMID:
12609530
8.

Titers of antibody to common pathogens: relation to food-based interventions in rural Kenyan schoolchildren.

Siekmann JH, Allen LH, Watnik MR, Nestel P, Neumann CG, Shoenfeld Y, Peter JB, Patnik M, Ansari AA, Coppel RL, Gershwin ME.

Am J Clin Nutr. 2003 Jan;77(1):242-9.

PMID:
12499348
9.

Monitoring HIV viral loads in the United States: recent trends and methodologies.

Peter JB, Blum RA.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):261-2. No abstract available.

PMID:
12045692
11.

Cytokine levels in various intravenous immunoglobulin (IVIg) preparations.

Sherer Y, Wu R, Krause I, Gorstein A, Levy Y, Peter JB, Shoenfeld Y.

Hum Antibodies. 2001;10(2):51-3.

PMID:
11673659
12.

Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations.

Sherer Y, Wu R, Kraus I, Peter JB, Shoenfeld Y.

Lupus. 2001;10(8):568-70.

PMID:
11530999
13.

Are autoantibodies present in patients with subacute and chronic urticaria?

Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME.

J Investig Allergol Clin Immunol. 2001;11(1):16-20.

PMID:
11436965
14.

Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.

Furst DE, Clements PJ, Wong WK, Mayes MD, Wigley F, White B, Weisman M, Barr W, Moreland L, Martin R, Medsger TA Jr, Steen V, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Peter JB, Seibold JR.

Rheumatology (Oxford). 2001 Jun;40(6):615-22.

PMID:
11426017
15.

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies.

Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Harats D, George J, Levy Y, Peter JB, Motro M, Shoenfeld Y.

Cardiology. 2001;95(1):20-4.

PMID:
11385187
16.
17.

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

Reiber H, Peter JB.

J Neurol Sci. 2001 Mar 1;184(2):101-22. Review.

PMID:
11239944
19.

Permanence of Fungi-Fluor epifluorescence stain to detect microsporidia.

Berlin OG, Conteas CN, Ash LR, Sorvillo F, Jacob CV, Yatabe J, Peter JB.

Am J Gastroenterol. 2000 Nov;95(11):3147-9.

PMID:
11095333
20.

Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment.

Levy Y, Sherer Y, Ahmed A, Fabbrizzi F, Terryberry J, Shen GQ, Peter JB, Shoenfeld Y.

Nat Immun. 1998;16(5-6):207-14.

PMID:
11061589
21.

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations.

Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G, Peter JB, Shoenfeld Y, Mathieu A.

Lupus. 2000;9(8):573-83. Erratum in: Lupus 2001;10(2):134.

PMID:
11035431
22.

Detection of antibodies to gangliosides and glycolipids in various intravenous immunoglobulin (IVIg) preparations.

Terryberry JW, Shoenfeld Y, Sherer Y, Levy Y, Fabrizzi F, Ahmed A, Peter JB.

Immunol Invest. 2000 Aug;29(3):337-47.

PMID:
10933614
23.

High, low, and very low viral loads of HIV in the United States.

Peter JB.

J Acquir Immune Defic Syndr. 2000 May 1;24(1):83-4. No abstract available.

PMID:
10877503
24.

Serum autoantibodies in patients with primary sclerosing cholangitis.

Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD.

J Hepatol. 2000 Feb;32(2):182-7.

PMID:
10707856
25.

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.

Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y.

Lupus. 1999;8(9):705-12.

PMID:
10602441
26.

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

Tumani H, Shen G, Peter JB, Brück W.

Arch Neurol. 1999 Oct;56(10):1241-6.

PMID:
10520940
27.

Rapid, hot chromotrope stain for detecting microsporidia.

Berlin OG, Ash LR, Conteas CN, Peter JB.

Clin Infect Dis. 1999 Jul;29(1):209. No abstract available.

PMID:
10433592
28.
29.

HIV viral loads reach steady state in the United States.

Peter JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):99-100. No abstract available.

PMID:
9928740
30.

Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.

Shen GQ, Shoenfeld Y, Peter JB.

Clin Rev Allergy Immunol. 1998 Fall;16(3):321-34. Review. No abstract available.

PMID:
9773259
31.

ANCA testing. New developments and clinical implications.

Ahmed AE, Peter JB, Shoenfeld YY.

Clin Rev Allergy Immunol. 1998 Fall;16(3):303-11. Review. No abstract available.

PMID:
9773257
32.

Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens.

Alosachie IJ, Terryberry JW, Mevorach D, Chapman Y, Lorber M, Torre D, Youinou P, Peter JB, Shoenfeld Y.

Clin Rev Allergy Immunol. 1998 Fall;16(3):275-84. No abstract available.

PMID:
9773254
33.

Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Terryberry JW, Shoenfeld Y, Peter JB.

Clin Rev Allergy Immunol. 1998 Fall;16(3):265-73. Review. No abstract available.

PMID:
9773253
34.

Autoantibodies in angioneurotic edema.

Ahmed AE, Peter JB, Shoenfeld Y.

Clin Rev Allergy Immunol. 1998 Fall;16(3):207-10. Review. No abstract available.

PMID:
9773247
35.

Hantavirus seropositivity in Israeli patients with renal failure.

George J, Patnaik M, Bakshi E, Levy Y, Ben-David A, Ahmed A, Peter JB, Shoenfeld Y.

Viral Immunol. 1998;11(2):103-8.

PMID:
9765032
36.
37.

Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis.

Terryberry JW, Thor G, Peter JB.

Neurobiol Aging. 1998 May-Jun;19(3):205-16.

PMID:
9661995
38.

Association of low concentrations of serum mannose-binding protein with recurrent infections in adults.

Kakkanaiah VN, Shen GQ, Ojo-Amaize EA, Peter JB.

Clin Diagn Lab Immunol. 1998 May;5(3):319-21.

39.
40.

Autofluorescence and the detection of cyclospora oocysts.

Berlin OG, Peter JB, Gagne C, Conteas CN, Ash LR.

Emerg Infect Dis. 1998 Jan-Mar;4(1):127-8. No abstract available.

41.

Declining HIV RNA viral loads in the United States.

Peter JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Feb 1;17(2):186. No abstract available.

PMID:
9473027
42.

Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection.

Yashina TL, Favorov MO, Khudyakov YE, Fields HA, Znoiko OO, Shkurko TV, Bonafonte T, Sevall JS, Agopian MS, Peter JB.

J Infect Dis. 1997 Jun;175(6):1302-7.

PMID:
9180167
43.

Silicates, silicones and autoimmunity.

Reyes H, Ojo-Amaize EA, Peter JB.

Isr J Med Sci. 1997 Apr;33(4):239-42. Review. No abstract available.

PMID:
9347870
44.

Antimicrobial resistance in India and the United States.

Peter JB.

Clin Infect Dis. 1996 Dec;23(6):1315-6. No abstract available.

PMID:
8953081
45.

Microbial resistance: global implications and strategies for combat.

Aziz DC, Peter JB.

J Assoc Physicians India. 1996 Aug;44(8):555-60. No abstract available.

PMID:
9251430
46.

Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution.

Hollingsworth PN, Dawkins RI, Peter JB.

Clin Diagn Lab Immunol. 1996 Jul;3(4):374-7.

47.
48.

Guillain-Barré as an autoimmune disease.

Shoenfeld Y, George J, Peter JB.

Int Arch Allergy Immunol. 1996 Apr;109(4):318-26.

PMID:
8634515
49.

Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity.

Shen GQ, Ojo-Amaize EA, Agopian MS, Peter JB.

Clin Diagn Lab Immunol. 1996 Mar;3(2):162-6.

50.

Carbohydrate-deficient transferrin evaluation in dry blood spots.

Bean P, Sutphin MS, Necessary P, Agopian MS, Liegmann K, Ludvigsen C, Peter JB.

Alcohol Clin Exp Res. 1996 Feb;20(1):56-60.

PMID:
8651463

Supplemental Content

Loading ...
Support Center